Canadian Accreditation Tools
Canadian Accreditation Tools
Canadian Accreditation Tools
OVERALL RESULTS
# of items met: 0
# of items not met: 0
STRENGTHS
2.0 The governing body has the appropriate membership to fulfill its role.
2.1 The mix of background, experience, and competencies needed in the governing body's membership is identified.
2.2 There are established mechanisms for the governing body to hear from and incorporate the voice and opinion of clients and families.
2.5 The roles and responsibilities of the chair are described in a position profile, terms of reference, or by-laws.
2.6 There are written criteria and a defined process for recruiting and selecting new members of the governing body.
2.7 New members of the governing body receive an orientation before attending their first meeting.
2.8 Each member of the governing body signs a statement acknowledging his or her role and responsibilities, including expectations of the
position and legal duties.
2.9 Members of the governing body receive ongoing education to help them fulfill their individual roles and responsibilities and those of the
governing body as a whole.
2.10 The governing body's membership policies and/or by-laws address term lengths and limits, attendance requirements, and
compensation.
2.11 The governing body's renewal cycle supports the addition of new members while maintaining a balance of experienced members to
support the continuity of corporate memory and decision-making.
ARU'2014 1
3.3 The information required to support decision making is available and accessible to the governing body.
3.4 The governing body has processes in place to oversee the functions of audit and finance, quality and safety, and talent management.
3.5 Required information and documentation is received in enough time to prepare for meetings and decision making.
3.6 The governing body reviews the type of information it receives to assess its appropriateness in helping the governing body to carry out its
role.
4.4 The organization's mission statement is regularly reviewed and revised as necessary to reflect changes in the environment, scope of
services, or mandate.
5.0 The governing body defines and models the organizational values.
5.1 The governing body works with the organization's leaders to define or update the organization's values statement.
5.2 The governing body collaborates with the organization's leaders to seek input from team members, clients, and families to define or
update the organization's values statement.
5.3 The governing body provides oversight of the organization's efforts to build meaningful partnerships with clients and families.
5.4 The governing body monitors and evaluates the organization's initiatives to build and maintain a culture of client- and family-centred care.
5.5 The governing body has a formal process to understand, identify, declare, and resolve conflicts of interest.
6.0 organization's vision and set the strategic plan, goals, and objectives.
6.1 The governing body oversees the strategic planning process and provides guidance to the organization's leaders as they develop and
update the organization's vision and strategic plan.
6.2 The governing body, in consultation with the organization's leaders, identifies timeframes and responsibility for achieving the strategic
goals and objectives.
6.3 The governing body works with the organization's leaders to conduct an ongoing environmental scan to identify changes and new
challenges, and ensures that the strategic plan, goals, and objectives are adjusted accordingly.
7.5 The governing body supports and commits resources to the ongoing professional development of the CEO.
7.8 The governing body has a succession plan for the CEO.
7.9 The governing body oversees the development of the organization's talent management plan.
8.0, The governing body oversees a process for granting and renewing privileges to health care
providers.
8.3 A documented process is followed for reviewing and renewing privileges (including processes for addition of new privileges or alteration of
privileges) on a regular basis.
8.4 There is a documented process to address any performance issues identified with health care professionals with privileges.
8.5 The governing body verifies that documented processes for appeals of decisions regarding privileges are followed.
9.0, The governing body has an effective system of financial planning and control
which supports achievement of the strategic goals and objectives.
9.1 The governing body approves the organization's capital and operating budgets.
ARU'2014 2
9.2 The governing body ensures the integrity of the organization's financial statements, internal controls, and financial information systems.
9.3 The governing body reviews the organization's financial performance in the context of the strategic plan and key performance areas such
as utilization, risk, and safety.
9.4 The governing body reviews and approves the organization's capital investments and major equipment purchases.
9.5 The governing body oversees the organization's resource allocation decisions as part of its regular planning cycle.
9.6 When reviewing and approving resource allocation decisions, the governing body assesses the risks and benefits to the organization.
9.7 When approving resource allocation decisions, the governing body evaluates the impact of the decision on quality, safety and client
experience.
9.8 The governing body anticipates the organization's financial needs and potential risks, and develops contingency plans to address them.
9.9 The governing body addresses recommendations in financial reports and from the CEO and the organization's leaders.
10.0, The governing body fosters and supports a culture of patient safety throughout
the organization.
10.1 The governing body adopts patient safety as a written strategic priority for the organization.
10.3 The governing body addresses recommendations made in the organization's quarterly patient safety reports.
10.4 The governing body regularly reviews the frequency and severity of safety incidents and uses this information to understand trends,
client and team safety issues in the organization, and opportunities for improvement.
10.5 The governing body regularly hears about quality and safety incidents from the clients and families that experience them.
11.1 The governing body works with the CEO to identify stakeholders and learn about their characteristics, priorities, interests, activities, and
potential to influence the organization.
11.2 In consultation with the CEO, the governing body anticipates, assesses, and responds to stakeholders' interests and needs.
11.3 The governing body works with the CEO to establish, implement, and evaluate a communication plan for the organization.
11.4 The communication plan includes strategies to communicate key messages to clients and families, team members, stakeholders, and
the community.
11.5 The governing body promotes the organization and demonstrates the value of its services to stakeholders and the community.
11.6 The governing body regularly consults with and encourages feedback from stakeholders and the community about the organization and
its services.
11.7 The governing body, in collaboration with the organization's leaders, share reports about the organization's performance and quality of
services with teams, clients, families, the community served, and other stakeholders.
12.0, The governing body works with the CEO to reduce risks to the organization and
promote ongoing quality improvement.
12.1 REQUIRED ORGANIZATIONAL PRACTICE: The governing body demonstrates accountability for the quality of care provided by the
organization.
12.1.1 The governing body is knowledgeable about quality and safety principles, by recruiting members with this knowledge or providing
access to education.
12.1.2 Quality is a standing agenda item at all regular meetings of the governing body.
12.1.3 The key system-level indicators that will be used to monitor the quality performance of the organization are identified.
12.1.4 At least quarterly, the quality performance of the organization is monitored and evaluated against agreed-upon goals and objectives.
12.1.5 Information about the quality performance of the organization is used to make resource allocation decisions and set priorities and
expectations.
12.1.6 As part of their performance evaluation, senior leaders who report to the governing body (e.g., the CEO, Executive Director, Chief of
Staff) are held accountable for the quality performance of the organization.
12.2 The governing body works with the CEO and the organization's leaders to develop an integrated quality improvement plan.
12.3 The governing body ensures that an integrated risk management approach and contingency plans are in place.
12.4 The governing body receives summary reports of client and family complaints received by the organization.
ARU'2014 3
12.5 The governing body monitors and provides input into the organization's strategies to address client flow and variations in service
demands.
12.6 The governing body promotes learning from results, making decisions that are informed by research and evidence, and ongoing quality
improvement for the organization and the governing body.
12.7 The governing body demonstrates a commitment to recognizing team members for their quality improvement work.
13.0, The governing body regularly evaluates the performance of individual board
members and its performance as a whole.
13.1 The governing body publicly discloses information about its governance processes, decision-making, and performance.
13.2 The governing body's activities and decisions are recorded and archived.
13.3 The governing body shares the records of its activities and decisions with the organization.
13.4 The governing body follows a process to regularly evaluate its performance and effectiveness.
13.5 The governing body conducts or participates in an assessment of its structure, including size and committee structure.
13.6 The governing body regularly evaluates the performance of the board chair based on established criteria.
13.7 The governing body regularly reviews the contribution of individual members and provides feedback to them.
13.8 ACCREDITATION CANADA REQUIRED INSTRUMENT: The governing body regularly assesses its own functioning using the
Governance Functioning Tool.
13.9 The governing body prepares an annual report of its achievements.
13.10 The governing body identifies and addresses opportunities for improvement in how it functions.
ARU'2014 4
Unit:
Dept.: Quality Department
Date:
Tracer
Team:
# of items completed: 0
% of applicable questions scored MET: #DIV/0!
Score Findings/Recommendations
ARU'2014 5
ARU'2014 6
ARU'2014 7
ARU'2014 8
Tracer Tool
Adapted from Canadian Accreditation Tool
INSTRUCTIONS: Work on a copy of this template.
- Select Score from the dropdown list.
- Press "Delete" to erase a selection.
- RE-SAVE FILE after making selections
OVERALL RESULTS
# of items met:
# of items not met:
STRENGTHS
4.1 A risk assessment is completed to identify high-risk activities, and the activities are addressed in policies and procedures.
4.2 There are policies and procedures that are in line with applicable regulations, evidence and best practices, and organizational priorities.
4.3 There are policies and procedures for using aseptic techniques when preparing, handling, and administering sterile substances both within the
preparation area and at the point of care.
4.4 There are policies and procedures for loaned, shared, consigned, and leased medical devices.
4.5 Team members and volunteers are provided with access to IPC policies and procedures.
4.6 Compliance with IPC policies and procedures is monitored and improvements are made to the policies and procedures based on the results.
4.7 IPC policies and procedures are updated regularly based on changes to applicable regulations, evidence, and best practices.
5.0, Team members, clients, families, and volunteers are engaged in promoting an
IPC culture within the organization.
5.1 A multi-faceted approach to promoting IPC is used within the organization.
5.2 Team members, clients and families, and volunteers are engaged when developing the multi-faceted approach for IPC.
5.3 The multi-faceted approach to IPC includes an education program tailored to IPC priorities, services, and client populations.
5.4 Information on how to safely perform high-risk activities is provided, including appropriately using PPE as outlined in its policies and procedures.
5.5 Team members and volunteers are required to attend the IPC education program at orientation and on a regular basis based on their IPC roles and
responsibilities.
5.6 The effectiveness of the multi-faceted approach for promoting IPC is evaluated regularly and improvements are made as needed.
6.2 Client, families, and visitors are provided with access to hand hygiene resources and PPE based on the risk of transmitting microorganisms.
6.3 Clients are screened to determine whether additional precautions are required based on the risk of infection.
7.3 There are policies and procedures for using PPE that are appropriate to the task.
7.4 There are work restrictions that are in line with OHS guidelines for team members, and volunteers with transmissible infections.
7.5 Policies, procedures, and legal requirements are followed when handling bio-hazardous materials.
7.6 There are policies and procedures for disposing of sharps at the point of use in appropriate puncture-, spill-, and tamper-resistant sharps containers.
8.6.1 Compliance with accepted hand-hygiene practices is measured using direct observation (audit). For organizations that provide services in clients'
homes, a combination of two or more alternative methods may be used, for example: • Team members recording
their own compliance with accepted hand-hygiene practices (self-audit). • Measuring product use.
• Questions on client
satisfaction surveys that ask about team members' hand-hygiene compliance. • Measuring the quality of
hand-hygiene techniques (e.g., through the use of ultraviolet gels or lotions).
8.6.2 Hand-hygiene compliance results are shared with team members and volunteers.
8.6.3 Hand-hygiene compliance results are used to make improvements to hand-hygiene practices.
9.2 Roles and responsibilities are assigned for cleaning and disinfecting the physical
environment.
9.3 There are policies and procedures for cleaning and disinfecting the physical environment and documenting this information.
9.4 There are policies and procedures for cleaning and disinfecting the rooms of clients who are on additional precautions.
9.5 Compliance with policies and procedures for cleaning and disinfecting the physical environment is regularly evaluated, with input from clients and
families, and improvements are made as needed.
9.6 When cleaning services are contracted to external providers, a contract is established and maintained with each provider that requires consistent levels
of quality and adherence to accepted standards of practice.
9.7 When cleaning services are contracted to external providers, the quality of the services provided is regularly monitored.
10.2 If neurosurgical services are provided, there are policies and procedures to prevent the transmission of Creutzfeldt-Jakob Disease (CJD).
10.3 Required training, education, and experience are defined for all team members that participate in cleaning, disinfecting, and/or sterilizing medical
devices and equipment.
10.4 Current manufacturers' instructions are upheld when cleaning, disinfecting, or sterilizing medical devices and equipment.
10.5 Policies, SOPs and manufacturers' instructions are accessible to all team members.
10.6 Cleaning, disinfection, and sterilization of critical and semi-critical single-use devices (SUD) is not permitted on-site, in line with the organization's policy
and regional regulations.
10.7 If cleaning, disinfection, or sterilization of reusable medical devices and equipment is contracted to external providers, a written agreement or contract
is maintained with each provider that outlines requirements and respective roles and responsibilities.
10.8 When cleaning, disinfection, or sterilization of reusable medical devices and equipment is contracted to external providers, the organization regularly
monitors the quality of the services provided.
10.9 When, cleaning, disinfection, and/or sterilization of medical devices or equipment is done in-house, team members involved in these processes are
provided with education and training in how to do so when they are first employed and on an ongoing
basis.
10.10 When an organization cleans, disinfects, and/or sterilizes devices and equipment in-house, there are designated and appropriate area(s) where these
activities are done.
10.11 The area where cleaning, disinfection, and/or sterilization of medical devices and equipment are done is equipped with hand hygiene facilities.
10.12 Eating and drinking, food storage, cosmetics application, and the contact lens handling are all prohibited in the area where cleaning, disinfection,
and/or sterilization of medical devices and equipment are done.
10.13 Items that require cleaning, disinfection, and/or sterilization are safely contained and transported to the appropriate area(s).
10.14 Appropriate Personal Protective Equipment (PPE) is worn when cleaning, disinfecting, or sterilizing medical devices and equipment.
10.15 Contaminated devices and equipment are cleaned before disinfection or sterilization is done.
10.16 Detergents, solutions, sterilants and disinfectants selected are in line with manufacturers' instructions, and are compatible with the devices being
cleaned, disinfected, or sterilized, and the equipment and processes for cleaning, disinfection or sterilization.
10.17 For each detergent, solution, sterilant, and disinfectant, manufacturers' instructions for use are followed.
10.18 Each device or set of devices are prepared for sterilization according to manufacturers' instructions.
10.19 An internal chemical indicator is placed in each package or container, according to the organization's quality control processes, to verify
that sterilizer penetration has occurred.
10.20 Sterilized packages are clearly identifiable and distinguished from non-sterilized items.
10.21 The integrity of each sterile package is maintained.
10.22 There is a process that allows for the tracking of medical devices associated with a sterilizer or sterilization cycle.
10.23 REQUIRED ORGANIZATIONAL PRACTICE: Processes for cleaning, disinfecting, and sterilizing medical devices and equipment are
monitored and improvements are made when needed.
10.23.1 There is evidence that processes and systems for cleaning, disinfection, and sterilization are effective.
10.23.2 Action has been taken to examine and improve processes for cleaning, disinfection, and sterilization where indicated.
11.0, Specific requirements are followed to reprocess flexible endoscopic devices.[Note: The following
criteria are additional requirements that apply specifically to reprocessing flexible endoscopes. Rigid
endoscopes are almost exclusivelycritical devices requiring sterilization, and are addressed by the other
standardsin this document.
11.1 Team members are trained on the policies and procedures for reprocessing flexible endoscopes.
11.2 Areas for reprocessing flexible endoscopes are physically separate from client care areas.
11.3 Endoscope reprocessing areas are equipped with separate cleaning and decontamination work areas as well as storage, dedicated
plumbing and drains, and proper air ventilation.
11.4 Manufacturers' instructions are followed to pre-clean flexible endoscopes immediately at point of use.
11.5 Before cleaning, the flexible endoscope is checked for internal and external damage, and if repair is required, the endoscope is prepared
and packaged for shipping in accordance with manufacturers' instructions.
11.6 Before beginning high-level disinfection, each flexible endoscope is cleaned, rinsed, and dried according to the manufacturer's instructions.
11.7 Before beginning high level disinfection, immersible endoscopic components are soaked and manually cleaned using water and an
approved cleaning agent.
11.8 Flexible endoscopes are stored in a manner that minimizes contamination and damage.
11.9 A permanent record is maintained of the reprocessing history for each flexible endoscope.
11.10 The record of endoscopic device reprocessing includes the identification number and the type of endoscope, the identification number of
the automated endoscope reprocessor (if applicable), the date and time of reprocessing, the name or unique identifier of the client, the results of
the individual inspection and leak test, and the name of the person reprocessing the endoscope.
11.11 Preventive and scheduled maintenance, including repairs, is completed and documented for each automated endoscope reprocessor.
12.3 There is a process to promptly detect suspected health care-associated infections in the organization.
12.4 There is access to a microbiology laboratory that offers expertise to the organization about identifying health care-associated infections.
12.5 Those responsible for receiving and responding to information about suspected health care-associated infections are identified.
12.6 The source or cause of health care-associated infections is investigated.
12.7 There are policies and procedures to contain and prevent the transmission of microorganisms by applying routine practices to all clients and
additional precautions as necessary.
12.8 IPC or public health experts are consulted with to control health care-associated infections, and the necessary information is reported to the
appropriate authorities in line with the applicable regulations.
12.9 Standard definitions and accepted statistical techniques are used to share and compare information about health care-associated infections.
12.10 The results of investigations are used to improve programs, policies, or procedures, and to prevent health care-associated infections from
recurring.
13.2 Team members and volunteers are provided with access to policies and procedures for identifying and managing outbreaks.
13.3 The organization collaborates with its partners, such as public health agencies, to define outbreaks in terms of person, place, and time.
13.4 Policies and procedures address how to manage emerging, rare, or problematic organisms, including antibiotic-resistant organisms.
13.5 There are policies and procedures about the roles and responsibilities of team members, and volunteers who are involved in identifying and
managing outbreaks.
13.6 Information is communicated about outbreaks to clients, families, team members, partners, other organizations, and the community when
appropriate.
13.7 Policies and procedures are regularly reviewed and improvements are made as needed following each outbreak.
14.5 Results of evaluations are shared with team members, volunteers, clients, and families.
py of this template.
own list.
ection.
elections
0
0
E IPC PROGRAM
es are maintained based on applicable regulations,
nd organizational priorities.
eted to identify high-risk activities, and the activities are addressed in policies and procedures.
cedures that are in line with applicable regulations, evidence and best practices, and organizational priorities.
cedures for using aseptic techniques when preparing, handling, and administering sterile substances both within the
oint of care.
s are updated regularly based on changes to applicable regulations, evidence, and best practices.
clients, families, and volunteers are engaged in promoting an
e organization.
to promoting IPC is used within the organization.
d families, and volunteers are engaged when developing the multi-faceted approach for IPC.
h to IPC includes an education program tailored to IPC priorities, services, and client populations.
ely perform high-risk activities is provided, including appropriately using PPE as outlined in its policies and procedures.
teers are required to attend the IPC education program at orientation and on a regular basis based on their IPC roles and
ulti-faceted approach for promoting IPC is evaluated regularly and improvements are made as needed.
s are provided with access to hand hygiene resources and PPE based on the risk of transmitting microorganisms.
termine whether additional precautions are required based on the risk of infection.
ed hand-hygiene practices is measured using direct observation (audit). For organizations that provide services in clients'
or more alternative methods may be used, for example: • Team members recording
cepted hand-hygiene practices (self-audit). • Measuring product use.
• Questions on client
bout team members' hand-hygiene compliance. • Measuring the quality of
, through the use of ultraviolet gels or lotions).
cedures for cleaning and disinfecting the physical environment and documenting this information.
cedures for cleaning and disinfecting the rooms of clients who are on additional precautions.
nd procedures for cleaning and disinfecting the physical environment is regularly evaluated, with input from clients and
re made as needed.
e contracted to external providers, a contract is established and maintained with each provider that requires consistent levels
ccepted standards of practice.
e contracted to external providers, the quality of the services provided is regularly monitored.
are provided, there are policies and procedures to prevent the transmission of Creutzfeldt-Jakob Disease (CJD).
tion, and experience are defined for all team members that participate in cleaning, disinfecting, and/or sterilizing medical
nstructions are upheld when cleaning, disinfecting, or sterilizing medical devices and equipment.
acturers' instructions are accessible to all team members.
d sterilization of critical and semi-critical single-use devices (SUD) is not permitted on-site, in line with the organization's policy
or sterilization of reusable medical devices and equipment is contracted to external providers, a written agreement or contract
der that outlines requirements and respective roles and responsibilities.
on, or sterilization of reusable medical devices and equipment is contracted to external providers, the organization regularly
rvices provided.
tion, and/or sterilization of medical devices or equipment is done in-house, team members involved in these processes are
raining in how to do so when they are first employed and on an ongoing
leans, disinfects, and/or sterilizes devices and equipment in-house, there are designated and appropriate area(s) where these
g, disinfection, and/or sterilization of medical devices and equipment are done is equipped with hand hygiene facilities.
d storage, cosmetics application, and the contact lens handling are all prohibited in the area where cleaning, disinfection,
devices and equipment are done.
ing, disinfection, and/or sterilization are safely contained and transported to the appropriate area(s).
otective Equipment (PPE) is worn when cleaning, disinfecting, or sterilizing medical devices and equipment.
terilants and disinfectants selected are in line with manufacturers' instructions, and are compatible with the devices being
zed, and the equipment and processes for cleaning, disinfection or sterilization.
olution, sterilant, and disinfectant, manufacturers' instructions for use are followed.
ndicator is placed in each package or container, according to the organization's quality control processes, to verify
s occurred.
re clearly identifiable and distinguished from non-sterilized items.
sterile package is maintained.
at allows for the tracking of medical devices associated with a sterilizer or sterilization cycle.
ZATIONAL PRACTICE: Processes for cleaning, disinfecting, and sterilizing medical devices and equipment are
ts are made when needed.
hat processes and systems for cleaning, disinfection, and sterilization are effective.
en to examine and improve processes for cleaning, disinfection, and sterilization where indicated.
ements are followed to reprocess flexible endoscopic devices.[Note: The following
al requirements that apply specifically to reprocessing flexible endoscopes. Rigid
ost exclusivelycritical devices requiring sterilization, and are addressed by the other
ument.
ained on the policies and procedures for reprocessing flexible endoscopes.
flexible endoscopes are physically separate from client care areas.
ng areas are equipped with separate cleaning and decontamination work areas as well as storage, dedicated
roper air ventilation.
exible endoscope is checked for internal and external damage, and if repair is required, the endoscope is prepared
n accordance with manufacturers' instructions.
level disinfection, each flexible endoscope is cleaned, rinsed, and dried according to the manufacturer's instructions.
level disinfection, immersible endoscopic components are soaked and manually cleaned using water and an
duled maintenance, including repairs, is completed and documented for each automated endoscope reprocessor.
icrobiology laboratory that offers expertise to the organization about identifying health care-associated infections.
receiving and responding to information about suspected health care-associated infections are identified.
f health care-associated infections is investigated.
procedures to contain and prevent the transmission of microorganisms by applying routine practices to all clients and
ecessary.
perts are consulted with to control health care-associated infections, and the necessary information is reported to the
e with the applicable regulations.
nd accepted statistical techniques are used to share and compare information about health care-associated infections.
gations are used to improve programs, policies, or procedures, and to prevent health care-associated infections from
olunteers are provided with access to policies and procedures for identifying and managing outbreaks.
borates with its partners, such as public health agencies, to define outbreaks in terms of person, place, and time.
es address how to manage emerging, rare, or problematic organisms, including antibiotic-resistant organisms.
procedures about the roles and responsibilities of team members, and volunteers who are involved in identifying and
icated about outbreaks to clients, families, team members, partners, other organizations, and the community when
es are regularly reviewed and improvements are made as needed following each outbreak.
# of items completed: 0
% of applicable questions scored MET: #DIV/0!
Score Findings/Recommendations
Tracer Tool
Adapted from Canadian Accreditation Tool
INSTRUCTIONS: Work on a copy of this template.
- Select Score from the dropdown list.
- Press "Delete" to erase a selection.
- RE-SAVE FILE after making selections
OVERALL RESULTS
# of items met: 0
# of items not met: 0
STRENGTHS
1.6, Input is sought from clients and families during the organization's key decision-making processes.
1.7 An ethics framework to support ethical practice is developed or adopted, and implemented with input from clients and
families.
1.8 The ethics framework defines processes for managing ethics issues, dilemmas, and concerns.
1.9 Accountability for the ethics framework and the processes to address ethics issues is assigned and monitored.
1.10 Support is provided to build the capacity of the governing body, leaders, and teams to use the ethics framework.
1.11 There is a process for gathering and reviewing information about trends in the organization's ethics issues, challenges,
and situations.
1.12 Information about trends in ethics issues, challenges, and situations is used to improve the quality of services.
1.13 The ethics framework includes a process for reviewing the ethical implications of any research activity that the
organization leads or participates in.
1.14 Research projects that the organization leads or participates in are reviewed by an objective reviewer or body.
2.0, A healthy and safe work environment and positive quality of worklife are
promoted and supported.
2.1 A healthy and safe work environment is identified as a strategic priority.
2.2 Support is provided for quality worklife and healthy and safe work environment improvement activities.
2.3 The organization's leaders take part in quality of worklife and healthy and safe work
environment improvement initiatives.
2.4 A code of conduct that applies to all those working in the organization is developed and
implemented.
2.5 A policy regarding reporting, investigating, and resolving behavior that contravenes the code of conduct is developed and
implemented.
2.6 Strategies are developed to help team members to manage their health.
2.7 There is a process in place to support leaders throughout the organization to develop their capabilities to promote a safe
and healthy work environment.
2.10 An immunization policy and associated procedures, which include recommending specific immunizations for team
members, are developed.
2.11 Team members' fatigue and stress levels are monitored and work is done to reduce safety risks associated with fatigue
and stress.
2.12 REQUIRED ORGANIZATIONAL PRACTICE: A documented and coordinated approach to prevent workplace violence is
implemented.
2.12.1 There is a written workplace violence prevention policy.
2.12.2 The policy is developed in consultation with team members and volunteers as appropriate.
2.12.3 The policy names the individual(s) or position responsible for implementing and monitoring adherence to the policy.
2.12.4 Risk assessments are conducted to ascertain the risk of workplace violence.
2.12.5 There are procedures for team members to confidentially report incidents of workplace violence.
2.12.6 There are procedures to investigate and respond to incidents of workplace violence.
2.12.7 The organization's leaders review quarterly reports of incidents of workplace violence and use this information to
improve safety, reduce incidents of violence, and improve the workplace violence prevention policy.
2.12.8 Information and training is provided to team members on them prevention of workplace violence.
2.13 A process is developed for team members to confidentially bring forward complaints, concerns, and grievances.
2.14 Process and outcome measures related to worklife and the work environment are identified and monitored.
2.15 ACCREDITATION CANADA REQUIRED INSTRUMENT: The quality of the organization's worklife culture is monitored using
the Worklife Pulse Tool.
3.4 There are clear, documented processes shared with clients and families about how to file a complaint about the
organization or their care or to report a violation of their rights.
3.5 Opportunities are provided for leaders throughout the organization to participate in collaborative quality improvement
initiatives.
3.6 There are regular dialogues between the organization's leaders and clients and families to solicit and use client and family
perspectives and knowledge on opportunities for improvement.
3.7 The organization's leaders are involved in leading quality improvement initiatives.
3.8 The spread and sustainability of quality improvement results is promoted and supported.
3.9 The organization's leaders promote learning from quality improvement results, and making decisions informed by
research and evidence, client experience, and ongoing quality improvement.
3.10 The organization's leaders promote and support the consistent use of standardized processes, decision-support tools, or
best practice guidelines to reduce variation in and between services, where appropriate.
3.11 Team members, clients, and families who participate in quality improvement initiatives are recognized for their work.
4.5 When developing the vision and strategic plan, risks and opportunities for the
organization are assessed.
4.6 The strategic plan identifies goals and objectives that are consistent with the mission and values and have measurable
outcomes.
4.7 An ongoing environmental scan is conducted to identify changes and new challenges, and the strategic plan, goals, and
objectives are adjusted as needed, with oversight and guidance from the governing body.
4.8 The organization's mission, vision, and values are shared with team members, clients and families, and the community.
4.9 The strategic goals and objectives are communicated to team members throughout the organization, and to clients and
families.
4.10 Goals and objectives at the team, unit, or program level align with the strategic plan.
4.11 The organization's progress toward achieving the strategic goals and objectives is reported to internal and external
stakeholders and the governing body where applicable.
4.12 Policies and procedures for all of the organization's primary functions, operations, and
systems are documented, authorized, implemented, and up to date.
5.0 The changing needs and health status of the community served are understood.
5.1 Information about the community's health status, capacities, and health care needs is collected or available to the
organization from other sources.
5.2 Information about the community is used to assist in planning the organization's scope of services.
5.3 Information about the community is maintained in a format that is up-to-date and easy to understand.
5.4 Information about the community is shared with the governing body, teams, and stakeholders, including other
organizations, clients, and families.
6.0, Operational plans are developed and implemented to achieve the strategic plan,
goals, and objectives.
6.1 Annual operational plans are developed to support the achievement of the strategic plan, goals, and objectives, and to
guide day-to-day operations.
6.2 When developing the operational plans, input is sought from team members, clients and families, and other
stakeholders, and the plans are communicated throughout the organization.
6.3 The operational plans identify the resources, systems, and infrastructure needed to deliver services and achieve the
strategic plan, goals and objectives.
6.4 The organization's structures and services or program areas are designed, implemented, and adapted as required to
support service delivery and achievement of the operational plans.
6.6 Management systems and tools are used to monitor and report on the implementation of operational plans.
7.2 The organization's leaders promote the organization and demonstrate the value of its services to stakeholders and the
community.
7.3 Partnerships are developed with other organizations in the community to efficiently and effectively deliver and
coordinate services.
7.4 The organization's leaders support and participate in ongoing community initiatives to promote health and prevent
disease.
7.5 There is an organization communication plan that addresses disseminating information to and receiving information from
internal and external stakeholders.
7.6 Input is sought from stakeholders on a regular basis to evaluate the effectiveness of their relationships with the
organization.
8.1 Resource allocation is a part of the regular planning cycle for the organization.
8.2 Annual operating and capital budgets are prepared according to the organization's financial policies and
procedures.
8.3 There are opportunities for leaders throughout the organization to receive education on how to manage and
monitor their budgets.
8.4 Input is gathered from external and internal stakeholders when making resource allocation decisions.
8.5 Set criteria are used to guide resource allocation decisions.
8.6 There is a process to have annual operating and capital budgets approved by the governing body.
8.7 There is a process to move resources to where they are needed most within and across operational and service
or program areas.
8.8 The impact of resource allocation decisions is regularly analyzed.
8.9 Budgets are monitored and regular reports are generated on the organization's financial performance.
8.10 Reports on financial performance include an analysis of the utilization of resources and outline opportunities to
improve the effective and efficient use of resources.
8.11 The organization's leaders verify that the organization meets legal requirements for managing financial
resources and financial reporting, e.g., audit, running a deficit.
9.4 There is a formal and open process for selecting and buying medical devices and equipment, and for selecting
qualified suppliers.
9.5 There is a process to provide education for teams on the safe operation of medical devices and equipment.
9.6 There is a procedure or policy to ensure that team members using specialized medical devices and equipment
are authorized and trained to do so.
9.7 Plans or processes for maintaining, upgrading, and replacing medical devices and equipment are followed.
9.8 REQUIRED ORGANIZATIONAL PRACTICE: A preventive maintenance program for medical devices, medical
equipment, and medical technology is implemented.
9.9 The organization's leaders develop and follow policies and procedures to manage patient safety incidents
involving medical devices, equipment, and technology, including cases involving misuse.
9.10 Steps, including introducing back-up systems, are taken to reduce the impact of utilities failures on client and
team health and safety.
9.11 Initiatives are undertaken to minimize the impact of the organization's operations on the environment.
10.0, The organization invests in its people and supports their professional
development.
10.1 Recruitment and selection of team members is conducted in an equitable manner according to individual
qualifications and their capability to contribute to the organization's values, goals, and objectives.
10.4 Education and training are provided throughout the organization to promote and enhance a culture of client-
and family-centred care.
10.5 There is a talent management plan that includes strategies for developing leadership capacity and capabilities
within the organization.
10.13 An exit interview is offered to team members that leave the organization, and the information is used to
improve performance, staffing, and retention.
10.14 Human resource records are maintained for all team members.
10.15 Human resource records are stored in a manner that protects individual privacy and meets applicable
regulations.
11.2 The privacy and confidentiality of client information are protected, in accordance with applicable legislation.
11.3 Policies and procedures to support the collection, entry, use, reporting, and retention of information are
implemented and reviewed and updated regularly.
11.4 There are policies and processes to allow clients to easily access the information in their health record in a
routine and timely way.
11.5 The organization's leaders manage access to and support and facilitate the flow of clinical and administrative
information throughout the organization, to the governing body, across departments, sites, or regional boundaries,
and to external partners and
the community.
11.6 Teams are provided with timely access to research-based evidence and leading and best practice information.
11.7 The quality and usefulness of the organizations' data and information are regularly assessed, and the
assessment results are used to improve the information systems.
12.3 As part of the integrated risk management approach, the organization's leaders develop risk mitigation plans.
12.4 The risk management approach and contingency plans are disseminated throughout the organization.
12.5 The effectiveness of the integrated risk management approach is regularly evaluated and improvements are
made as necessary.
12.6 As part of the integrated risk management approach, established policies and procedures are followed for
selecting and negotiating contracted services and contracted service providers.
12.7 As part of the integrated risk management approach, the quality of contracted services and contracted service
providers is regularly evaluated.
13.3 The organization's leaders collaborate with other service providers and partners to improve and optimize client
flow.
13.4 REQUIRED ORGANIZATIONAL PRACTICE: Client flow is improved throughout the organization and
emergency department overcrowding is mitigated by working proactively with internal teams and teams from other
sectors. NOTE: This ROP only applies to organizations with an emergency department that can admit clients.
14.2 An all-hazard disaster and emergency response plan is developed and implemented.
14.3 The all-hazard disaster and emergency response plan is aligned with those of partner organizations and local,
regional, and provincial governments.
14.4 Education is provided to support the all-hazard disaster and emergency response plan.
14.5 The organization's all-hazard disaster and emergency response plans are regularly tested with drills and
exercises to evaluate the state of response preparedness.
14.6 The results from post-drill analysis and debriefings are used to review and revise the all-hazard disaster and
emergency response plans and procedures as necessary.
14.7 An incident management system is developed and implemented to direct and coordinate actions and
operations during and after disasters and emergencies.
14.10 The business continuity plan addresses back-up systems for essential utilities and systems during and
following emergency situations.
14.11 When disasters or emergencies occur, teams, clients, and the community are provided with support and
debriefing opportunities.
15.2 Responsibility for implementing and monitoring the patient safety plan and for leading patient safety
improvement activities is assigned to a council, committee, group, or
individual.
15.8 At least one patient safety-related prospective analysis has been conducted within the last year and
appropriate improvements are made as a result.
16.4 The organization has uploaded a client experience report for applicable services. Please refer to the current
client experience requirement documentation in the client portal for more information.
16.5 Action has been taken on the client experience tool results.
16.6 Opportunities for quality improvement are identified based on trends in patient safety incidents, performance
data, patient experience data, feedback from Client and Family advisory councils and other sources, and plans are
developed to prioritize and address those opportunities.
16.7 The organization's leaders verify that the quality improvement plans and related changes are implemented.
16.8 Regular reports about the organization's performance are generated and shared with the governing body,
where applicable.
16.9 Reports about the organization's performance and quality of services are shared with the team, clients,
families, the community served, and other partners and stakeholders.
16.10 The results of the organization's quality improvement activities are communicated broadly, as appropriate.
Unit:
# of items completed: 0
% of applicable questions scored MET: #DIV/0!
Findings/Recommendations
Tracer Tool
Adapted from Canadian Accreditation Tool
INSTRUCTIONS: Work on a copy of this template.
- Select Score from the dropdown list.
- Press "Delete" to erase a selection.
- RE-SAVE FILE after making selections
OVERALL RESULTS
# of items met:
# of items not met:
STRENGTHS
Medication Management
PLANNING THE MEDICATION MANAGEMENT SYSTEM
1.0 An interdisciplinary committee is responsible for managing medications in the
organization.
1.1 The interdisciplinary committee has defined roles and responsibilities for medication
management that are in line with legislation and applicable regulations.
1.3 The role of the interdisciplinary committee is regularly evaluated and improvements are
made as needed.
2.2 The interdisciplinary committee has a process to monitor research and best practice
information on medication management and uses the information to update medication
management processes.
2.6 The interdisciplinary committee has policies to oversee the security of all controlled
substances.
2.7 The interdisciplinary committee approves standardized order sets for medications.
2.8 Critical information for medication administration is standardized and is used on
medication orders, medication labels, and in medication administration records.
2.9 The interdisciplinary committee establishes standard medication administration
schedules.
2.10 The interdisciplinary committee shall develop and implement standardized protocols
and/or coupled order sets that permit the emergency administration of all appropriate
antidotes, reversal agents, and rescue agents used in the facility.
2.13 There is a procedure to handle medications brought into the organization by clients
and families.
2.14 The organization has a policy and procedure to manage medication shortages.
2.15 The organization has a procedure to determine which medications can be stored in
client service areas.
3.0 Pharmacists are deployed within interprofessional clinical teams and play an
integral and proactive role in client-engaged medication management.
3.1 The organization integrates pharmacists into designated interprofessional clinical
teams to provide proactive care for client-engaged medication management.
3.2 Pharmacists collaborate with clients and interprofessional clinical teams to provide care using evidence-informed care activities associated with improved client and
system outcomes
3.3 The organization has developed local implementation action plans that include prioritizing which high-risk client populations or units receive the evidence-informed care
activities from pharmacists.
5.2 Teams are educated about how to prevent, recognize, respond to, and report patient safety incidents involving medications.
6.2 Teams have timely access to the client medication profile and essential client information.
8.0 If a computerized prescriber order entry (CPOE) system is used, appropriate and
up-to-date clinical decision support is provided.
8.1 The type of alerts used by the CPOE system includes, at minimum, alerts for medication interactions, medication allergies, and maximum doses for high-alert medications
8.2 A policy is developed and implemented on when and how to override the CPOE system alerts.
8.3 Medication information stored in the CPOE system is updated annually.
8.4 The CPOE system is regularly tested to ensure alerts fire as expected.
8.5 Alert fatigue is managed by regularly evaluating the type of alerts required by the CPOE system based on best practice information and by collecting input from teams.
8.6 The CPOE system is integrated with other information systems used for medication management.
9.0 The pharmacy computer system used to manage medications is up to date and uses appropriate alerts.
9.1 Medication information stored in the pharmacy computer system is updated annually.
9.2 There is a process to determine the type and level of alerts required by the pharmacy computer system that includes, at minimum, alerts for medication interactions,
medication allergies, and minimum and maximum doses for high-alert medications.
9.3 A policy for when and how to override alerts by the pharmacy computer system is developed and implemented.
9.4 Alert fatigue is managed by regularly evaluating the type of alerts required by the pharmacy computer system, based on best practice information and input from teams.
10.4 REQUIRED ORGANIZATIONAL PRACTICE: The availability of narcotic products is evaluated and limited to ensure that formats with the potential to cause patient safety
incidents are not stocked in client service areas.
10.5 The organization has a procedure to identify and resolve concerns with medication shipments.
10.6 Medications are returned when they are formally recalled or discontinued by an external body such as a government agency or the manufacturer.
11.0 There is a procedure to select and procure medication delivery devices (e.g., syringes, insulin pens, infusion
pumps).
11.1 There is a procedure to assess, evaluate, document, and reconcile the potential harms
and benefits of medication delivery devices before purchase.
11.3 There are limited brands and models of general purpose infusion pumps, syringe pumps, and patient-controlled analgesia pumps available in the organization.
14.0 Hazardous medications are safely stored in client service areas and medication
preparation areas.
14.1 Raw materials used for compounding are regularly assessed to determine if they should be discarded when they are not regularly used or are considered
dangerous.
14.2 Regulations for handling raw materials used for compounding in the pharmacy, including storage and cleaning up spills, are followed.
14.3 Chemotherapy medications are stored in a separate negative pressure room with adequate ventilation and are segregated from other supplies where
possible.
14.4 Anesthetic gases and volatile liquid anesthetic agents are stored in an area with adequate ventilation, as per the manufacturer's instructions.
15.1 A structured program has been implemented to reduce the risks associated with polypharmacy, especially with frail or vulnerable clients.
15.2 The team regularly evaluates intravenous therapy in clients using an established intravenous to oral conversion program that has been approved by the
interdisciplinary committee.
15.3 A standardized procedure is followed when sending medication orders to the pharmacy.
15.4 Standardized, pre-printed forms shall be used to order medications that are commonly prescribed or have been identified as high risk.
15.5 There is a policy for acceptable medication orders, with criteria being developed or revised, implemented, and regularly evaluated, and the policy is revised
as necessary.
15.6 REQUIRED ORGANIZATIONAL PRACTICE: A list of abbreviations, symbols, and dose designations that are not to be used have been identified and
implemented.
15.7 Disease-specific protocols and pre-printed or electronic orders are used for chemotherapy orders.
15.8 Steps are taken to reduce distractions, interruptions, and noise when team members,are prescribing medications or transcribing and verifying medication
orders.
15.9 There is a policy on telephone and verbal orders for medications that specifies when such orders are acceptable, how they are to be documented, and whe
they are to be co-signed by the prescriber.
15.10 Medication orders are accurately transcribed into clinical documents such as medication administration records.
15.11 The organization uses regular, documented audits to assess the accuracy of medication order documentation and makes improvements as needed as pa
of a continuous quality improvement program.
PREPARING MEDICATIONS
16.0 The pharmacist reviews all medication orders for accuracy and appropriateness
16.1 The pharmacist reviews each medication order prior to the first dose being administered
16.2 The pharmacist performs an independent double check for the dosing calculations of pediatric weight-based protocols.
16.3 The pharmacist performs an independent double check for the dosing calculations for chemotherapeutic agents that are dosed according to weight or body
surface area.
16.4 A team member contacts the prescriber if there are concerns about or changes required to a medication order and documents the results of the discussion
(e.g., a corrected medication order) in the client record.
17.4 Sterile products are prepared in a separate area that meets standards for aseptic compounding.
17.5 Direct contact with hazardous medications is avoided while the medications are being prepared.
17.6 Accurate and up-to-date records are maintained for all medications that are compounded or repackaged in the pharmacy.
17.7 Accurate and up-to-date information is maintained for all medications dispensed by the pharmacy or client service area, and includes, at minimum, the date
and quantity.
18.3 Unit dose oral medications are kept in manufacturer or pharmacy packaging until they are administered.
18.4 Concerns with medication names, packaging, or labelling are identified, reported to the pharmacy or manufacturer, and shared with team members in the
pharmacy and in client service areas.
19.3 Emergency, urgent, and routine medications are accessible within the timelines set by the organization.
19.4 When automated dispensing cabinets are used, there are policies and procedures that address access, location, type of medication information, verification
and restocking of medications.
19.5 Automated dispensing cabinets in client service areas interface with the medication order entry management system.
20.0 The organization has a process for controlled access to medications when the pharmacy is closed.
20.1 When the pharmacy is closed, there is controlled access to a night cabinet or to automated dispensing cabinet for a limited selection of urgently required
medications.
20.2 A record is kept of the medications accessed from the night cabinet or automated dispensing cabinet.
20.3 A pharmacist or other qualified team member verifies, as soon as possible, that the correct medications were obtained from the automated dispensing
cabinet or night cabinet after hours.
20.4 The system for dispensing medications when the pharmacy is closed is regularly evaluated and improvements are made as needed.
21.3 A readily accessible hazardous spill kit is located wherever cytotoxic or other hazardous medications are dispensed and administered.
21.4 There is a procedure to manage the return of medications to the pharmacy.
21.5 The organization has a policy and procedure to manage how it procures and tracks medications.
22.2 At the time of admission, information on how to prevent patient safety incidents involving medications is provided to and discussed with clients and families
22.3 Information is shared with each client about who to contact and how to reach that person if they have concerns or questions about their medications while
receiving care, at transfer of service, or at the end of service.
22.4 Team members reinforce medication information that is provided to clients and families and respond to concerns or questions they may have about their
medication.
23.0 The organization works with clients and families to manage self-administration of
medications safely.
23.1 There is a policy and procedure to ensure client self-administration of medication is safely managed.
23.2 Established criteria are used to determine which medications clients can selfadminister.
23.3 Established criteria are used to assess whether a client is able to self-administer medications.
23.4 Medications that are self-administered by clients are stored and labelled safely and appropriately.
23.5 Each client who self-administers medications is provided with appropriate education and supervision prior to self-administration, and this is documented in
the client record.
23.6 The process for self-administering medications includes documenting in the client record that the client took the medication and when it was taken.
24.0 The organization has processes to ensure medications are administered safely and accurately.
24.1 Team members who administer medications are assigned a level of responsibility that is within their scope of practice
24.2 Before medication is administered, the client’s profile is consulted to verify the “rights” of medication administration, which are the right medication, the righ
dose, the right route, the right time, to the right person, with the right documentation, for the right reason, and with the right response.
24.3 The organization establishes a list of high-alert medications that require an independent double check before they are administered.
24.4 An independent double check of high-alert medications identified by the organization is conducted at the point of care before these medications are
administered.
24.5 To allow for immediate administration during emergencies, antidotes, reversal agents, and rescue agents shall be available to team members along with
standardized protocols or coupled order sets and directions for use.
24.6 When using medications intended for the topical use in surgical procedures, such as concentrated epinephrine, it is not drawn up into a parenteral syringe
but placed in a labelled bowl within the sterile field.
24.7 When using any medication intended for injection, it is drawn into the syringe from the original vial and labelled immediately prior to use.
24.8 In the event of a delayed or missed medication dose, the team documents the actual time of administration in the client record.
24.9 Teams address medication-related concerns with a prescriber or pharmacist and follow established guidelines to notify the prescriber or pharmacist as
required.
24.10 Lot numbers and expiry dates for vaccines are documented in the client record following administration of the medication.
25.0 There are policies and procedures to ensure team members are competent to safely assist clients with their
medications.
25.1 Team members who assist with medications are provided with appropriate training, at orientation and on an ongoing basis, to maintain competency.
25.2 Team members who assist with medications are educated on how to recognize allergic reactions and how to respond if a reaction occurs.
25.3 Team members who assist with medications have access to a regulated health care professional who can answer their questions about medications.
26.2 The effects of medications on client treatment goals are monitored and documented in the client record.
26.3 Clients are monitored for possible patient safety incidents involving medications.
26.4 Alerts or alarms on client monitoring systems are used to alert team members and service providers immediately of potential patient safety incidents.
26.5 The organization discloses patient safety incidents involving medications to the client and family at the earliest opportunity.
29.0 The interdisciplinary committee oversees a quality improvement program for medication management.
29.1 Resources are provided to support quality improvement activities for medication management.
29.2 When medication management processes are contracted to external providers, a contract is established and maintained with each provider that requires
consistent
29.3 Whenlevels of quality
medication and adherence
management to accepted
processes standards
are contracted to of practice.
external providers, the quality of the services is regularly monitored by reviewing the evidence
from the external contractors.
29.4 The interdisciplinary committee conducts an annual evaluation of the medication management system.
29.5 The interdisciplinary committee monitors process and outcome indicators for medication management.
29.6 The interdisciplinary committee prioritizes and completes medication use evaluations.
29.7 The interdisciplinary committee uses the information it collects about its medication management system to identify successes and opportunities for
improvement, and to ensure that improvements are made in a timely way.
29.8 The interdisciplinary committee shares evaluation results, areas of success, and opportunities for improvement with teams.
py of this template.
own list.
ection.
elections
0
0
gement Score
MEDICATION MANAGEMENT SYSTEM
ary committee is responsible for managing medications in the
mittee has defined roles and responsibilities for medication
with legislation and applicable regulations.
ith clients and interprofessional clinical teams to provide care using evidence-informed care activities associated with improved client and
loped local implementation action plans that include prioritizing which high-risk client populations or units receive the evidence-informed care
MPETENCY EVALUATION
ted about how to manage medications.
e in orientation prior to their first shift and receive continuing education and training based on their roles and responsibilities for managing
e of practice.
t how to prevent, recognize, respond to, and report patient safety incidents involving medications.
omputer system used to manage medications is up to date and uses appropriate alerts.
ored in the pharmacy computer system is updated annually.
mine the type and level of alerts required by the pharmacy computer system that includes, at minimum, alerts for medication interactions,
mum and maximum doses for high-alert medications.
PROCURING MEDICATIONS
ess to select and procure medications that have received formulary approval.
with its partners to encourage differentiation among products with similar labelling and packaging.
g, the organization purchases commercially manufactured medications when they are available.
NAL PRACTICE: The availability of heparin products is evaluated and limited to ensure that formats with the potential to cause patient safety
ent service areas.
NAL PRACTICE: The availability of narcotic products is evaluated and limited to ensure that formats with the potential to cause patient safety
ent service areas.
d when they are formally recalled or discontinued by an external body such as a government agency or the manufacturer.
edure to select and procure medication delivery devices (e.g., syringes, insulin pens, infusion
and models of general purpose infusion pumps, syringe pumps, and patient-controlled analgesia pumps available in the organization.
r compounding are regularly assessed to determine if they should be discarded when they are not regularly used or are considered
ng raw materials used for compounding in the pharmacy, including storage and cleaning up spills, are followed.
tions are stored in a separate negative pressure room with adequate ventilation and are segregated from other supplies where
volatile liquid anesthetic agents are stored in an area with adequate ventilation, as per the manufacturer's instructions.
ND ORDERING MEDICATIONS
prescribed and ordered safely, and the technical requirements of the medication order are met.
has been implemented to reduce the risks associated with polypharmacy, especially with frail or vulnerable clients.
aluates intravenous therapy in clients using an established intravenous to oral conversion program that has been approved by the
ATIONAL PRACTICE: A list of abbreviations, symbols, and dose designations that are not to be used have been identified and
cols and pre-printed or electronic orders are used for chemotherapy orders.
uce distractions, interruptions, and noise when team members,are prescribing medications or transcribing and verifying medication
ephone and verbal orders for medications that specifies when such orders are acceptable, how they are to be documented, and when
the prescriber.
DICATIONS
reviews all medication orders for accuracy and appropriateness
s each medication order prior to the first dose being administered
ms an independent double check for the dosing calculations of pediatric weight-based protocols.
ms an independent double check for the dosing calculations for chemotherapeutic agents that are dosed according to weight or body
cts the prescriber if there are concerns about or changes required to a medication order and documents the results of the discussion
n order) in the client record.
PACKAGING MEDICATIONS
of patient safety incidents involving medications is reduced through appropriate medication
, and nomenclature.
or units are labelled in a standardized manner.
s all sterile products with a label that, at minimum, includes the name of the medication, the base solution, and the total amount of
ions are kept in manufacturer or pharmacy packaging until they are administered.
ion names, packaging, or labelling are identified, reported to the pharmacy or manufacturer, and shared with team members in the
ice areas.
D DELIVERING MEDICATIONS
dispensed in a safe, secure, and timely manner.
uality assurance process to ensure that medications are accurately dispensed as ordered.
nsed in unit dose packaging and exclusions (e.g., liquids, topical preparations, antacids, otic/ophthalmics, multi-dose vials) are
olicy.
d routine medications are accessible within the timelines set by the organization.
ensing cabinets are used, there are policies and procedures that address access, location, type of medication information, verification,
ns.
cabinets in client service areas interface with the medication order entry management system.
n has a process for controlled access to medications when the pharmacy is closed.
closed, there is controlled access to a night cabinet or to automated dispensing cabinet for a limited selection of urgently required
qualified team member verifies, as soon as possible, that the correct medications were obtained from the automated dispensing
r hours.
sing medications when the pharmacy is closed is regularly evaluated and improvements are made as needed.
azardous spill kit is located wherever cytotoxic or other hazardous medications are dispensed and administered.
o manage the return of medications to the pharmacy.
a policy and procedure to manage how it procures and tracks medications.
n, information on how to prevent patient safety incidents involving medications is provided to and discussed with clients and families.
with each client about who to contact and how to reach that person if they have concerns or questions about their medications while
f service, or at the end of service.
ce medication information that is provided to clients and families and respond to concerns or questions they may have about their
dministering medications includes documenting in the client record that the client took the medication and when it was taken.
blishes a list of high-alert medications that require an independent double check before they are administered.
e check of high-alert medications identified by the organization is conducted at the point of care before these medications are
administration during emergencies, antidotes, reversal agents, and rescue agents shall be available to team members along with
oupled order sets and directions for use.
ns intended for the topical use in surgical procedures, such as concentrated epinephrine, it is not drawn up into a parenteral syringe
l within the sterile field.
ation intended for injection, it is drawn into the syringe from the original vial and labelled immediately prior to use.
ed or missed medication dose, the team documents the actual time of administration in the client record.
ation-related concerns with a prescriber or pharmacist and follow established guidelines to notify the prescriber or pharmacist as
ry dates for vaccines are documented in the client record following administration of the medication.
es and procedures to ensure team members are competent to safely assist clients with their
ssist with medications are provided with appropriate training, at orientation and on an ongoing basis, to maintain competency.
ssist with medications are educated on how to recognize allergic reactions and how to respond if a reaction occurs.
ssist with medications have access to a regulated health care professional who can answer their questions about medications.
ons on client treatment goals are monitored and documented in the client record.
or possible patient safety incidents involving medications.
ent monitoring systems are used to alert team members and service providers immediately of potential patient safety incidents.
oses patient safety incidents involving medications to the client and family at the earliest opportunity.
ommittee determines which team members to involve in the analysis of patient safety incidents involving medications.
safety incidents involving medications, the interdisciplinary committee exchanges information with clients, families, and other team
ded actions and improvements that were made.
# of items completed: 0
% of applicable questions scored MET: #DIV/0!
Findings/Recommendations
Tracer Tool
Adapted from Canadian Accreditation Tool
INSTRUCTIONS: Work on a copy of this template.
- Select Score from the dropdown list.
- Press "Delete" to erase a selection.
- RE-SAVE FILE after making selections
OVERALL RESULTS
# of items met:
# of items not met:
STRENGTHS
1.5 Workload is assessed and team members are reassigned as required during periods of high volume and surges in the emergency department.
3.4 Pertinent client information is transferred in collaboration with Emergency Medical Services (EMS).
3.5 Equipment and supplies that are appropriate for pediatric clients are available and accessible.
4.6 After the initial triage assessment, clients who are waiting for service are advised which team member to contact if their condition changes.
4.7 There is ongoing communication with clients who are waiting for services.
4.8 Clients waiting in the emergency department are monitored for possible deterioration of condition and are reassessed as appropriate.
6.0 Clients who present to the emergency department are effectively assessed.
6.1 Each client's physical and psychosocial health is assessed and documented using a holistic approach, in partnership with the client and family.
6.2 The assessment process is designed with input from clients and families.
6.3 Goals and expected results of the client's care and services are identified in partnership with the client and family.
6.4 Standardized assessment tools are used during the assessment process.
6.5 REQUIRED ORGANIZATIONAL PRACTICE:In partnership with clients, families, or caregivers (as appropriate), the medication reconciliation process is initiated for clients wit
to admit, and can be completed on the receiving unit.
6.6 Universal fall precautions, applicable to the setting, are identified and implemented to ensure a safe environment that prevents falls and reduces the risk of injuries from
6.7 REQUIRED ORGANIZATIONAL PRACTICE:Clients are assessed and monitored for risk of suicide.
6.8 Each client's preferences and options for services are discussed as part of the assessment, in partnership with the client and family.
6.9 Options and preferences for pain management are discussed with the client.
6.10 An assessment of the client's palliative and end-of-life care needs is completed, where appropriate, in partnership with the client and family.
6.11 Priority access to diagnostic services and laboratory testing and results is available 24 hours a day, 7 days a week.
6.12 Evidence-based protocols are used to select diagnostic imaging services for pediatric clients.
6.13 Urgent medications and pharmacy staff can be accessed 24 hours a day, 7 days a week.
6.14 Priority access to consultation services is available 24 hours a day, 7 days a week.
6.15 There is timely access to specialists with expertise in pediatric health.
6.16 A process is followed to communicate and validate client diagnoses when there is discrepancy between the initial diagnosis and diagnostic imaging or laboratory results.
6.17 The client's health status is reassessed in partnership with the client, and updates are documented in the client record, particularly when there is a change in health stat
6.18 The results of the assessment are shared with the client and other team members in a timely and easy-to-understand way.
6.19 A comprehensive and individualized care plan is developed and documented in partnership with the client and family.
6.20 Client progress toward achieving goals and expected results is monitored in partnership with the client, and the information is used to adjust the care plan as necessary.
6.21 Planning for care transitions, including end of service, are identified in the care plan in partnership with the client and family.
7.0 Potential organ and tissue donors are identified and referred in a timely and effective manner.
7.1 There are established protocols and policies on organ andmtissue donation.
7.2 There is a policy on neurological determination of death (NDD).
7.3 There is a policy to transfer potential organ donors to another level of care once they have been identified.
7.4 There are established clinical referral triggers to identify potential organ and tissue donors.
7.5 Training and education on organ and tissue donation and the role of the organization and the emergency department is provided to the team.
7.6 Training and education on how to support and provide information to families of potential organ and tissue donors is provided to the team, with input from clients and fa
7.7 When death is imminent or established for potential donors, the Organ Procurement Organization (OPO) or tissue centre is notified in a timely manner.
7.8 All aspects of the donation process are recorded in the client record, including the family's decision about organ and tissue donation.
8.0 Safe and effective care is provided to clients in the emergency department.
8.1 The client's individualized care plan is followed when services are provided.
8.2 All services received by the client, including changes and adjustments to the care plan, are documented in the client record.
8.3 Client privacy is respected during registration.
8.4 An established procedure, such as the use of armbands, is used to identify clients in the emergency department.
8.5 Assigned roles and responsibilities are adhered to during the resuscitation of clients.
8.6 REQUIRED ORGANIZATIONAL PRACTICE:Working in partnership with clients and families, at least two personspecific identifiers are used to confirm that clients receive the
procedure intended for them.
8.7 Treatment protocols are consistently followed to provide the same standard of care in all settings to all clients.
8.8 Clients with known or suspected infectious diseases are identified, isolated, and managed.
8.9 Clients who have received sedatives or narcotics are monitored.
8.10 Emergency and advanced resuscitation equipment, supplies, and materials are available in the room where procedural sedation is administered.
8.11 Information on pediatric medication dosages is available and accessible to the team.
8.12 Medications are administered to pediatric clients using weight-based pediatric dosages and appropriately sized equipment.
8.13 Access to spiritual space and care is provided to meet clients' needs.
8.14 Clients and families have access to psychosocial and/or supportive care services, as required.
8.15 There is a process for initiating palliative and end-of-life care, as required.
8.16 Support for the family, team members, and other clients is provided throughout and following the death of a client.
8.17 REQUIRED ORGANIZATIONAL PRACTICE:Information relevant to the care of the client is communicated effectively during care transitions.
8.18 Information obtained from Emergency Medical Services, triage, assessment, and admissions is transferred to service providers in the next setting.
9.0 Clients and families are partners in planning and preparing for transition to another service or setting.
9.1 Clients and families are actively engaged in planning and preparing for transitions in care.
9.2 Clinical guidelines are used to determine whether a client is fit for transfer of care.
9.3 The client's physical and psychosocial readiness for transition, including their capacity to self-manage their health, is assessed.
9.4 Clients are empowered to self-manage conditions by receiving education, tools, and resources, where applicable.
9.5 Appropriate follow-up services for the client, where applicable, are coordinated in collaboration with the client, family, other teams, and organizations.
9.6 The transition plan is documented in the client record.
9.7 A client's wish to end or limit services, transfer to another service, or transition home, is respected.
9.8 The client's risk of readmission is assessed, where applicable, and appropriate follow-up is coordinated.
9.9 The effectiveness of transitions is evaluated and the information is used to improve transition planning, with input from clients and families.
10.2 Ambulance offload response times are measured and used to set target times for clients brought to the emergency department by Emergency Medical Serv
10.3 Data on wait times for services, the length of stay in the emergency department, and the number of clients who leave without being seen is tracked and ben
py of this template.
own list.
ection.
elections
0
0
team members are reassigned as required during periods of high volume and surges in the emergency department.
ssment, clients who are waiting for service are advised which team member to contact if their condition changes.
cation with clients who are waiting for services.
rgency department are monitored for possible deterioration of condition and are reassessed as appropriate.
ommunicate and validate client diagnoses when there is discrepancy between the initial diagnosis and diagnostic imaging or laboratory results.
is reassessed in partnership with the client, and updates are documented in the client record, particularly when there is a change in health status.
ment are shared with the client and other team members in a timely and easy-to-understand way.
ividualized care plan is developed and documented in partnership with the client and family.
chieving goals and expected results is monitored in partnership with the client, and the information is used to adjust the care plan as necessary.
ons, including end of service, are identified in the care plan in partnership with the client and family.
nd tissue donors are identified and referred in a timely and effective manner.
tocols and policies on organ andmtissue donation.
ogical determination of death (NDD).
r potential organ donors to another level of care once they have been identified.
cal referral triggers to identify potential organ and tissue donors.
organ and tissue donation and the role of the organization and the emergency department is provided to the team.
how to support and provide information to families of potential organ and tissue donors is provided to the team, with input from clients and families.
r established for potential donors, the Organ Procurement Organization (OPO) or tissue centre is notified in a timely manner.
n process are recorded in the client record, including the family's decision about organ and tissue donation.
consistently followed to provide the same standard of care in all settings to all clients.
uspected infectious diseases are identified, isolated, and managed.
ed sedatives or narcotics are monitored.
ced resuscitation equipment, supplies, and materials are available in the room where procedural sedation is administered.
c medication dosages is available and accessible to the team.
istered to pediatric clients using weight-based pediatric dosages and appropriately sized equipment.
ce and care is provided to meet clients' needs.
ve access to psychosocial and/or supportive care services, as required.
initiating palliative and end-of-life care, as required.
team members, and other clients is provided throughout and following the death of a client.
ATIONAL PRACTICE:Information relevant to the care of the client is communicated effectively during care transitions.
om Emergency Medical Services, triage, assessment, and admissions is transferred to service providers in the next setting.
ies are partners in planning and preparing for transition to another service or setting.
actively engaged in planning and preparing for transitions in care.
sed to determine whether a client is fit for transfer of care.
d psychosocial readiness for transition, including their capacity to self-manage their health, is assessed.
to self-manage conditions by receiving education, tools, and resources, where applicable.
ervices for the client, where applicable, are coordinated in collaboration with the client, family, other teams, and organizations.
cumented in the client record.
limit services, transfer to another service, or transition home, is respected.
mission is assessed, where applicable, and appropriate follow-up is coordinated.
nsitions is evaluated and the information is used to improve transition planning, with input from clients and families.
ponse times are measured and used to set target times for clients brought to the emergency department by Emergency Medical Services.
services, the length of stay in the emergency department, and the number of clients who leave without being seen is tracked and benchmarked.
Unit:
# of items completed: 0
% of applicable questions scored MET: #DIV/0!
Findings/Recommendations